T&L Co. Ltd (340570) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.68 Billion ≈ $6.56 Million USD) by net assets (₩199.09 Billion ≈ $134.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See T&L Co. Ltd (340570) defensive interval to measure how many days the company can operate on defensive assets alone.

T&L Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Antibiotice Ia
RO:ATB
-0.042x
Argo Global Listed Infrastructure Ltd
AU:ALI
0.034x
RichWave Technology Corp
TW:4968
-0.010x
Ningbo Tianyi Medical Appliance Co. Ltd.
SHE:301097
N/A
Rotshtein
TA:ROTS
-0.082x
RPSG VENTURES LIMITED
NSE:RPSGVENT
0.209x
Haymaker Acquisition Corp. 4
NYSE:HYAC
-0.215x
Harbin VITI Electronics Corp
SHG:603023
-0.020x

Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see T&L Co. Ltd (340570) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩171.44 Billion
≈ $116.18 Million
₩46.57 Billion
≈ $31.56 Million
0.272x +7.98%
2023-12-31 ₩129.55 Billion
≈ $87.80 Million
₩32.59 Billion
≈ $22.09 Million
0.252x +73.19%
2022-12-31 ₩106.07 Billion
≈ $71.88 Million
₩15.41 Billion
≈ $10.44 Million
0.145x -31.15%
2021-12-31 ₩90.09 Billion
≈ $61.05 Million
₩19.01 Billion
≈ $12.88 Million
0.211x +62.45%
2020-12-31 ₩71.95 Billion
≈ $48.76 Million
₩9.34 Billion
≈ $6.33 Million
0.130x -44.91%
2019-12-31 ₩33.23 Billion
≈ $22.52 Million
₩7.83 Billion
≈ $5.31 Million
0.236x +0.50%
2018-12-31 ₩27.24 Billion
≈ $18.46 Million
₩6.39 Billion
≈ $4.33 Million
0.235x --

About T&L Co. Ltd

KQ:340570 Korea Medical Devices
Market Cap
$313.69 Million
₩462.88 Billion KRW
Market Cap Rank
#14692 Global
#488 in Korea
Share Price
₩57500.00
Change (1 day)
+2.31%
52-Week Range
₩43550.00 - ₩65500.00
All Time High
₩84000.00
About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more